Abiraterone acetate plus Prednisone/Prednisolone compared with Enzalutamide in metastatic castration resistant prostate cancer before or after chemotherapy: A retrospective study of real‐world data (ACES)

BACKGROUND: Abiraterone acetate combined with Prednisone/Prednisolone (AA+P) and Enzalutamide (ENZ) have proven survival benefit in men with metastatic castration‐resistant prostate cancer (mCRPC) in chemotherapy‐naïve and prior chemotherapy patients. There have been no studies directly comparing th...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Prantik, Taylor, Sarah, Price, James, Jones, Michael, Martin‐Fernandez, Cristina, Ali, Akram, Mugunthan, Thangrarajh, Mallik, Chandrani, Ward, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988641/
https://www.ncbi.nlm.nih.gov/pubmed/35474912
http://dx.doi.org/10.1002/bco2.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988641/
https://www.ncbi.nlm.nih.gov/pubmed/35474912
http://dx.doi.org/10.1002/bco2.11

Ejemplares similares